secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioCardia, Inc. (BCDA)
CIK:        0000925741
Form:       8-K
Filed at:   2026-04-15T23:59:59+00:00
Accession:  0001437749-26-012412
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

BioCardia receives Nasdaq delisting notice for equity shortfall; has until May 25 to submit compliance plan
--------------------------------------------------------------------------------

- Stockholders' equity was $895,000 as of Dec. 31, 2025, well below the $2.5M minimum required by Nasdaq Listing Rule 5550(b)(1).
- Notice received April 10, 2026; company must submit a plan to regain compliance by May 25, 2026.
- If Nasdaq accepts the plan, it may grant up to 180 days from April 10 to evidence compliance.
- Common stock continues trading on Nasdaq Capital Market under symbol BCDA; no immediate effect on listing.
- Failure to regain compliance could lead to delisting; company intends to submit a plan and may request a hearing if plan is rejected.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/925741/000143774926012412/0001437749-26-012412-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/925741/000143774926012412/bcda20260414_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-012412

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer